Glucagon-like peptide-1 receptor agonists associated with improved clinical outcomes in patients with inflammatory bowel disease: a retrospective cohort study

Feyzullah Aksan; Alan Abboud; Lokman Hekim Tanrıverdi; Olga C. Aroniadis; Farah Monzur

doi:10.1007/s00210-025-04745-0

Back

Glucagon-like peptide-1 receptor agonists associated with improved clinical outcomes in patients with inflammatory bowel disease: a retrospective cohort study

Article 2025 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2017

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

M. Angelyn Bethel, Rishi Patel, Peter Merrill, Yuliya Lokhnygina, John B. Buse, Robert J. Mentz, Neha J. Pagidipati, Juliana C.N. Chan, Stephanie M. Gustavson, Nayyar Iqbal, Aldo Maggioni, Peter Öhman, Neil R Poulter, Ambady Ramachandran, Bernard Zinman, Adrian F. Hernandez, Rury R. Holman

Article2025

Potential Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Diabetes and High Risk for Dementia

Germán Plascencia‐Villa, Rong Xu, George Perry

Article2016

Persistent Eosinophilia in Inflammatory Bowel Disease Patients Is Associated with Poorer Long Term Clinical Outcomes

Jennifer Cahill, Yelena Zadvornova, Dilpesh Agrawal, Dan Joseph Stein

Article2025

Clinical Outcomes of Patients with MGUS and Diabetes/Obesity on GLP-1 Receptor Agonists: A Real-World, Propensity-Matched Study

Ioannis Ntanasis‐Stathopoulos, Anastasios Tentolouris, Charalampos Filippatos, Αlexandros Briasoulis, Meletios A Dimopoulos, Maria Gavriatopoulou

Article2024

SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation

Yi‐Hsin Chan, Tze‐Fan Chao, Shao-Wei Chen, Hsin‐Fu Lee, Pei‐Ru Li, Yung‐Hsin Yeh, Chi‐Tai Kuo, Lai‐Chu See, Professor Gregory Lip